Two trials were performed to evaluate the effect of a dietary supplementation with Bacillus cereus var. toyoi on performance and health of growing rabbits. The studies were conducted in two commercial farms using the same experimental diets. In the first trial, 216 rabbits were controlled from 35 d (weaning) until 70 d of age. In the second trial, 180 rabbits were controlled from 37 until 79 d of age. At weaning, rabbits were put into bicellular cages, divided into three groups and fed the experimental diets: diet C, diet T1 and diet T2 supplemented with 0, 200 ppm (2x10 5 spores/g diet) and 1000 ppm (1x10 6 spores/g diet) of Toyocerin ® (concentration: 1x10 9 B. cereus var. toyoi spores/g), respectively. The diets did not contain antibiotics or growth promoters and presented similar chemical composition (CP: 17.4% DM, NDF: 40.8% DM; ADL: 5.2% DM, starch: 16.5% DM). The differences in growth performance between the two trials depended mainly on the different final age of rabbits. Weight gain (42.0 vs 36.5 g/d) was lower and feed conversion (3.12 vs 3.96) higher in the second trial. Mortality (13.0% vs 21.7%) and morbidity (2.8% vs 25.0%) were significantly higher in the second trial. The probiotic supplementation (diet C vs diets T1+T2) significantly increased final live weight (2,517 vs 2,580 g; P=0.02) and daily weight gain (38.2 vs 39.8 g/d; P=0.01) and improved feed conversion (3.63 vs 3.50; P=0.01). Morbidity was significantly lower with supplemented diets (18.2 vs 10.3%; P=0.03), while mortality and sanitary risk were not affected by dietary treatment. No effect of probiotic inclusion rate (diet T1 vs diet T2) and no significant interaction between dietary treatment and trial were measured. In conclusion, the supplementation of Bacillus cereus var. toyoi improved growth performance and reduced morbidity of rabbits reared in farms with or without severe health problems. Increasing probiotic inclusion rate from 2x10 5 to 1x10 6 spores/g diet did not improve rabbit growth performance and health.
INTRODUCTION
The spread of enteric diseases and in particular epizootic rabbit enteropathy (ERE) has negatively affected the health status in rabbit farms and largely increased antibiotic use as a preventive method DUPERRAY et al., 2003) .
However, on the base of consumer demand, European legislation is banning the use of antibiotics as growth promoters and is working towards a reduction of therapeutic antibiotics for all livestock production, to avoid crossed resistance in humans and improve food safety. Probiotics and prebiotics appear as possible alternative feed additives to modulate intestinal microflora and improve animal health (WILLIAMS and NEWBOLD, 1996; BOSI et al., 2001; MEDINA et al., 2002) . In rabbits, live yeast supplementation provided some positive effects on growth performance and health status, especially when animals were kept under sub-optimal environmental and sanitary conditions with high stocking density and low hygiene control (MAERTENS and DE GROOTE, 1992; TEDESCO et al., 1994; MAERTENS and DUCATELLE, 1996) . Lactic-acid bacteria could modify caecal microflora composition (CANZI et al., 2000) , but seems to have weak effects on growth performance and mortality of growing rabbits (YAMANI et al., 1992) . Various strains of Bacillus sp. were tested with contrasting results (DE BLAS et al., 1991; ZOCCARATO et al., 1995; BONANNO et al., 1996) . Few studies were performed under experimental conditions testing the action and efficacy of Bacillus cereus var. toyoi (HATTORI et al., 1984; NICODEMUS et al., 2004) .
In the present study, two trials were performed to evaluate the effect of a dietary supplementation of Bacillus cereus var. toyoi on performance and health status of growing rabbits kept in bicellular cages in two typical Italian commercial farms.
MATERIALS AND METHODS

Trial location and equipment
Two trials were performed in two commercial farms located in the North-East of Italy (Padova province), characterised by a similar housing and management conditions. In both farms, the buildings were made of concrete. The trials were performed in the autumn-winter period, but the environmental conditions were controlled by an automatic heating system regulated to maintain a minimum temperature of 16°C during the whole trial. cm. The temperature during the pellet conditioning did not exceed 60°C and no water was added (humidity 9-10%).
The diets were similar to common commercial diets for growing rabbits and formulated using commercial raw materials currently adopted by Italian feed producers. They did not contain antibiotics, additives, growth promoters or coccidiostatics.
The diets presented similar chemical composition (average value of the two trials), as expected, since differing only for the probiotic inclusion (Table 1) . Very little differences in composition could be attributed to the method of diet preparation, (with three successive stages), ingredient loading, mixing and pelleting (according to the sequence: diet C, diet T1 and diet T2). In general, the chemical composition of the diets was in accordance with current requirements for growing rabbits (DE BLAS and MATEOS, 1998) .
Recordings
At weaning, the rabbits were given identification marks on the ear, put into bicellular cages and fed the experimental diets. Individual live weight and cage feed intake were recorded weekly. Mortality was controlled daily throughout the experimental period. Daily feed intake was calculated taking into account the effective number of animals per cage per day, thus excluding the intake of dead animals.
The general health status of rabbits was controlled daily by the breeder with a visual inspection to detect the presence of dead or ill animals, these latter showing sign of diarrhoea or prostration. All rabbits were examined individually the day of weighing to detect the occurrence of digestive or respiratory problems. The rabbits were considered ill when evidencing clear signs of diarrhoea or a reduction of live weight and/or a 20% decrease of daily feed intake compared to the previous week.
In the calculation of morbidity, the ill rabbits were counted only once, independently of the duration of illness. The dead animals were not considered in the morbidity calculation. The health risk was calculated as the sum of morbidity and mortality (BENNEGADI et al., 2000) . The animals were kept under control by the official veterinary service of the farm. The dead animals were submitted to veterinary inspection at the Istituto Zooprofilattico Sperimentale delle Venezie (Legnaro, Padova, Italy) to determine the causes of death.
In the first trial, mortality amounted to 8 rabbits per diet C, 8 rabbits per diet T1 and 12 rabbits per diet T2. The number of cages (with one or two rabbits) considered for statistical analysis was 35, 35 and 33 for diet C, diet T1 and diet T2, respectively.
In the second trial, mortality was 12 rabbits per diet C, 15 rabbits per diet T1 and 12 rabbits per diet T2. The number of cages considered for statistical analysis was 28, 28 and 29 for diet C, diet T1 and diet T2, respectively.
Chemical analysis
The diets were analysed by AOAC (2000) 
Statistical analysis
Data were analysed using the GLM procedure of the Statistical Analysis Systems (SAS, 1991) according to a 2x2 factorial arrangement with the type of diet, the trial and their interaction as the main sources of variation and the cage as the experimental unit. Comparisons among means of the three dietary treatments were performed using the Bonferroni test and the contrast "control vs probiotic supplementation": C vs T = C vs (T1+T2). Differences in mortality and morbidity of rabbits according to the dietary treatment, the trial and their interaction were tested using the CATMOD procedure of SAS.
RESULTS AND DISCUSSION
Growth performance of rabbits are reported in Table 2 . The effects of the main experimental factors are described and discussed separately, since no significant interaction was measured (P>0.10). Differences in growth performance between the two trials depended mainly on the different final age (70 and 79 d). Growth performances in the two trials were also affected by the different health status of animals (Table 3) . Mortality (13.0% vs 21.7%) and morbidity (2.8% vs 25.0%) were significantly higher during the second trial. Health problems were mainly due to diarrhoea or mucoid enteritis with the presence of E. coli and often Clostridium sp. In the first trial, health problems appeared at the end of the first week of trial and reduced by the beginning of the third week. In the second trial, health problems appeared in the second week and persisted until the beginning of the fourth week.
Regardless of the health condition, the effect of the probiotic inclusion was In terms of productive performance, the inclusion of B. subtilis did not always improve growth or health status of growing rabbits (CRISTOFALO et al., 1980; LAMBERTINI et al., 1990) . On the other hand, when B. subtilis was associated with B.
licheniformis, growth rate, feed conversion and digestive efficiency increased (ZOCCARATO et al., 1995; BONANNO et al., 1999) . In the case of unfavourable sanitary farm conditions (average mortality: 23%), mortality was reduced to 5% with the highest dietary level of Bacillus sp. (BONANNO et al., 1996) . The supplementation of 
CONCLUSIONS
The supplementation of B. cereus var. toyoi at the dose of 2x10 5 spores/g diet by means of Toyocerin ® improved moderately the growth performance, and reduced Probiotic and prebiotic supplementation in rabbit feeding represents a promising way of reducing antibiotic utilization and offers safer meat to the consumer. More studies are needed, however, to evaluate the action and test the efficacy of commercial products as well as to identify and develop new additives.
